At the news
? NEUTRALIMPACT 2/10 144 filed Jun 10, 2026 at 16:45 ET
Director Daniella Beckman filed a Form 144 notice of intent to sell 4,446 shares of Tango Therapeutics common stock, with an approximate market value of $133,380 based on a $30.00 reference price. The shares being sold amount to less than 0.01% of the company's $4.6B market cap and represent stock acquired through option exercise and restricted stock vesting. This is a routine and immaterial insider sale by a director, consistent with compensation-related share liquidation.
- Director Daniella Beckman filed Form 144 to sell 4,446 shares of Tango Therapeutics
- Approximate market value of proposed sale: $133,380
- Shares acquired via stock option exercise (914 shares) and restricted stock vesting (3,532 shares from 2017 grants)
- Sale represents ~0.003% of $4.6B market cap, immaterial dilution concern
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access